
Immunai and Parker Institute to Build Massive Cancer Single-Cell Dataset
Immunai, an AI biotech company specializing in mapping the human immune system, and the Parker Institute for Cancer Immunotherapy (PICI), a San Francisco-based nonprofit organization that unites leading immuno-oncology experts from cancer centers across …